Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CARA |
---|---|---|
09:32 ET | 9311 | 0.6442 |
09:36 ET | 200 | 0.667 |
09:38 ET | 400 | 0.65 |
09:50 ET | 100 | 0.6585 |
10:01 ET | 1500 | 0.652142 |
10:03 ET | 2100 | 0.6584 |
10:08 ET | 120 | 0.6584 |
10:15 ET | 100 | 0.65 |
10:17 ET | 100 | 0.65 |
10:19 ET | 6226 | 0.66588 |
10:24 ET | 350 | 0.661651 |
10:37 ET | 100 | 0.6545 |
10:39 ET | 100 | 0.661 |
10:46 ET | 240 | 0.661 |
10:53 ET | 100 | 0.6656 |
10:55 ET | 100 | 0.6595 |
11:04 ET | 1000 | 0.66 |
11:06 ET | 850 | 0.6595 |
11:08 ET | 100 | 0.6595 |
11:13 ET | 18278 | 0.6593 |
11:18 ET | 854 | 0.6534 |
11:20 ET | 377 | 0.6539 |
11:26 ET | 100 | 0.6564 |
11:27 ET | 4700 | 0.6594 |
11:29 ET | 100 | 0.6565 |
11:33 ET | 2100 | 0.6537 |
11:36 ET | 100 | 0.6594 |
11:38 ET | 1189 | 0.656408 |
11:42 ET | 4510 | 0.6537 |
11:44 ET | 100 | 0.6592 |
11:51 ET | 100 | 0.6537 |
11:56 ET | 200 | 0.6538 |
11:58 ET | 100 | 0.6564 |
12:02 ET | 299 | 0.6538 |
12:07 ET | 100 | 0.6538 |
12:18 ET | 100 | 0.6538 |
12:21 ET | 100 | 0.6538 |
12:23 ET | 7100 | 0.6587 |
12:25 ET | 500 | 0.6587 |
12:32 ET | 600 | 0.6559 |
12:34 ET | 100 | 0.6538 |
12:36 ET | 130 | 0.6562 |
12:38 ET | 100 | 0.6563 |
12:43 ET | 896 | 0.654 |
12:45 ET | 300 | 0.6539 |
12:48 ET | 400 | 0.6563 |
12:50 ET | 395 | 0.655653 |
12:56 ET | 100 | 0.6539 |
01:03 ET | 400 | 0.6532 |
01:06 ET | 100 | 0.6533 |
01:08 ET | 813 | 0.65325 |
01:15 ET | 100 | 0.6528 |
01:21 ET | 400 | 0.6531 |
01:24 ET | 100 | 0.6531 |
01:32 ET | 100 | 0.6523 |
01:37 ET | 865 | 0.6523 |
01:39 ET | 100 | 0.6533 |
01:44 ET | 1493 | 0.6528 |
01:48 ET | 100 | 0.6529 |
01:50 ET | 506 | 0.65305 |
01:51 ET | 100 | 0.6528 |
01:53 ET | 403 | 0.6529 |
01:55 ET | 100 | 0.6524 |
02:00 ET | 5390 | 0.6518 |
02:08 ET | 6753 | 0.6413 |
02:09 ET | 470 | 0.6569 |
02:13 ET | 4374 | 0.655563 |
02:20 ET | 100 | 0.6417 |
02:22 ET | 200 | 0.6569 |
02:27 ET | 200 | 0.642 |
02:31 ET | 500 | 0.645 |
02:36 ET | 2407 | 0.642 |
02:42 ET | 333 | 0.6432 |
02:44 ET | 1062 | 0.6437 |
02:45 ET | 400 | 0.6417 |
02:56 ET | 11981 | 0.635 |
02:58 ET | 275 | 0.6372 |
03:00 ET | 100 | 0.635 |
03:02 ET | 2437 | 0.6375 |
03:03 ET | 100 | 0.6313 |
03:05 ET | 572 | 0.6354 |
03:07 ET | 500 | 0.63565 |
03:09 ET | 1050 | 0.6373 |
03:12 ET | 700 | 0.6453 |
03:14 ET | 783 | 0.6429 |
03:16 ET | 5169 | 0.6453 |
03:21 ET | 900 | 0.644 |
03:25 ET | 607 | 0.644 |
03:27 ET | 800 | 0.6425 |
03:30 ET | 1158 | 0.6446 |
03:32 ET | 522 | 0.6439 |
03:39 ET | 1613 | 0.6425 |
03:41 ET | 341 | 0.6412 |
03:43 ET | 100 | 0.641 |
03:45 ET | 596 | 0.64135 |
03:48 ET | 1965 | 0.6434 |
03:50 ET | 718 | 0.6492 |
03:52 ET | 300 | 0.6499 |
03:54 ET | 2310 | 0.6498 |
03:56 ET | 421 | 0.6498 |
03:57 ET | 1298 | 0.6492 |
03:59 ET | 38477 | 0.6629 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cara Therapeutics Inc | 36.8M | -0.3x | --- |
ImmuCell Corp | 33.5M | -8.6x | --- |
Aadi Bioscience Inc | 42.7M | -0.7x | --- |
Turnstone Biologics Corp | 62.7M | -0.8x | --- |
SQZ Biotechnologies Co | 1.1M | 0.0x | --- |
Prenetics Global Ltd | 72.8M | -1.2x | --- |
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated with Notalgia Paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back. It is conducting Phase II/III Clinical Program in NP. The program is comprised of two studies - KOURAGE 1 and KOURAGE 2, which are double-blind, placebo-controlled, eight-week studies with patients allowed to roll-over into open-label 52-week extensions. It has developed an IV formulation of difelikefalin, for the treatment of moderate-to-severe pruritus associated with advanced chronic kidney disease in adults undergoing hemodialysis. The IV formulation is out-licensed worldwide.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $36.8M |
---|---|
Revenue (TTM) | $16.9M |
Shares Outstanding | 54.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.77 |
EPS | $-2.26 |
Book Value | $1.05 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 2.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -729.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.